• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性心肌病中的线粒体自噬:作用与机制

Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms.

作者信息

Zheng Haoxiao, Zhu Hailan, Liu Xinyue, Huang Xiaohui, Huang Anqing, Huang Yuli

机构信息

Department of Cardiology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, China.

Guangdong Provincial Key Laboratory of Shock and Microcirculation Research, Guangzhou, China.

出版信息

Front Cell Dev Biol. 2021 Sep 27;9:750382. doi: 10.3389/fcell.2021.750382. eCollection 2021.

DOI:10.3389/fcell.2021.750382
PMID:34646830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8503602/
Abstract

Cardiovascular disease is the leading complication of diabetes mellitus (DM), and diabetic cardiomyopathy (DCM) is a major cause of mortality in diabetic patients. Multiple pathophysiologic mechanisms, including myocardial insulin resistance, oxidative stress and inflammation, are involved in the development of DCM. Recent studies have shown that mitochondrial dysfunction makes a substantial contribution to the development of DCM. Mitophagy is a type of autophagy that takes place in dysfunctional mitochondria, and it plays a key role in mitochondrial quality control. Although the precise molecular mechanisms of mitophagy in DCM have yet to be fully clarified, recent findings imply that mitophagy improves cardiac function in the diabetic heart. However, excessive mitophagy may exacerbate myocardial damage in patients with DCM. In this review, we aim to provide a comprehensive overview of mitochondrial quality control and the dual roles of mitophagy in DCM. We also propose that a balance between mitochondrial biogenesis and mitophagy is essential for the maintenance of cellular metabolism in the diabetic heart.

摘要

心血管疾病是糖尿病(DM)的主要并发症,而糖尿病性心肌病(DCM)是糖尿病患者死亡的主要原因。多种病理生理机制,包括心肌胰岛素抵抗、氧化应激和炎症,都参与了DCM的发生发展。最近的研究表明,线粒体功能障碍在DCM的发生发展中起重要作用。线粒体自噬是一种发生在功能失调线粒体中的自噬类型,它在线粒体质量控制中起关键作用。虽然DCM中线粒体自噬的确切分子机制尚未完全阐明,但最近的研究结果表明,线粒体自噬可改善糖尿病心脏的心脏功能。然而,过度的线粒体自噬可能会加重DCM患者的心肌损伤。在这篇综述中,我们旨在全面概述线粒体质量控制以及线粒体自噬在DCM中的双重作用。我们还提出,线粒体生物合成和线粒体自噬之间的平衡对于维持糖尿病心脏的细胞代谢至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5750/8503602/b288de18d752/fcell-09-750382-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5750/8503602/9cff297cb43d/fcell-09-750382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5750/8503602/0f1283e069e4/fcell-09-750382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5750/8503602/e9aad8bab17e/fcell-09-750382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5750/8503602/b288de18d752/fcell-09-750382-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5750/8503602/9cff297cb43d/fcell-09-750382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5750/8503602/0f1283e069e4/fcell-09-750382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5750/8503602/e9aad8bab17e/fcell-09-750382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5750/8503602/b288de18d752/fcell-09-750382-g004.jpg

相似文献

1
Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms.糖尿病性心肌病中的线粒体自噬:作用与机制
Front Cell Dev Biol. 2021 Sep 27;9:750382. doi: 10.3389/fcell.2021.750382. eCollection 2021.
2
Myocardial redox status, mitophagy and cardioprotection: a potential way to amend diabetic heart?心肌氧化还原状态、线粒体自噬与心脏保护:改善糖尿病性心脏的潜在途径?
Clin Sci (Lond). 2016 Sep 1;130(17):1511-21. doi: 10.1042/CS20160168.
3
Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies.糖尿病心肌病中线粒体质量控制:从分子机制到治疗策略。
Int J Biol Sci. 2022 Aug 15;18(14):5276-5290. doi: 10.7150/ijbs.75402. eCollection 2022.
4
Mitochondrial Quality Control Mechanisms during Diabetic Cardiomyopathy.糖尿病心肌病中的线粒体质量控制机制
JMA J. 2022 Oct 17;5(4):407-415. doi: 10.31662/jmaj.2022-0155. Epub 2022 Sep 30.
5
The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy.线粒体异常在糖尿病心肌病中的作用。
Int J Mol Sci. 2022 Jul 16;23(14):7863. doi: 10.3390/ijms23147863.
6
Diabetes cardiomyopathy: targeted regulation of mitochondrial dysfunction and therapeutic potential of plant secondary metabolites.糖尿病心肌病:线粒体功能障碍的靶向调控及植物次生代谢产物的治疗潜力
Front Pharmacol. 2024 Jul 9;15:1401961. doi: 10.3389/fphar.2024.1401961. eCollection 2024.
7
Mst1 inhibits Sirt3 expression and contributes to diabetic cardiomyopathy through inhibiting Parkin-dependent mitophagy.Mst1 通过抑制 Parkin 依赖性线粒体自噬抑制 Sirt3 表达,导致糖尿病心肌病。
Biochim Biophys Acta Mol Basis Dis. 2019 Jul 1;1865(7):1905-1914. doi: 10.1016/j.bbadis.2018.04.009. Epub 2018 Apr 17.
8
Melatonin activates Parkin translocation and rescues the impaired mitophagy activity of diabetic cardiomyopathy through Mst1 inhibition.褪黑素通过抑制 Mst1 激活 Parkin 易位,挽救糖尿病心肌病受损的线粒体自噬活性。
J Cell Mol Med. 2018 Oct;22(10):5132-5144. doi: 10.1111/jcmm.13802. Epub 2018 Jul 31.
9
Mitochondrial quality control mechanisms as molecular targets in diabetic heart.糖尿病心脏中的线粒体质量控制机制作为分子靶点。
Metabolism. 2022 Dec;137:155313. doi: 10.1016/j.metabol.2022.155313. Epub 2022 Sep 17.
10
Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological Strategies.糖尿病心肌病发病机制的新见解及药理学策略
Front Cardiovasc Med. 2021 Dec 23;8:707336. doi: 10.3389/fcvm.2021.707336. eCollection 2021.

引用本文的文献

1
The clinical impact of mitochondrial autophagy on very late-onset recurrence after catheter ablation for atrial fibrillation.线粒体自噬对房颤导管消融术后极晚期复发的临床影响。
Eur Heart J Open. 2025 May 17;5(3):oeaf058. doi: 10.1093/ehjopen/oeaf058. eCollection 2025 May.
2
Exercise Empowerment: A Multifaceted Anatomy in Managing Diabetic Myocardial Disorder.运动赋能:管理糖尿病性心肌病的多维度剖析
J Cardiovasc Transl Res. 2025 Jun 4. doi: 10.1007/s12265-025-10630-1.
3
Dysregulation of Mitochondrial in Pulmonary Hypertension-Related Right Ventricular Remodeling: Pathophysiological Features and Targeting Drugs.

本文引用的文献

1
Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus.二甲双胍单药治疗或联合治疗与 2 型糖尿病患者心血管风险的关系。
Cardiovasc Diabetol. 2021 Jan 30;20(1):30. doi: 10.1186/s12933-020-01202-5.
2
Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control: Role of SIRT6.褪黑素通过改善线粒体质量控制减轻糖尿病性心肌病并降低心肌对缺血-再灌注损伤的易感性:SIRT6的作用
J Pineal Res. 2021 Jan;70(1):e12698. doi: 10.1111/jpi.12698. Epub 2020 Oct 24.
3
BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1/Parkin-mediated mitophagy in vivo.
肺动脉高压相关右心室重构中线粒体的失调:病理生理特征与靶向药物
Rev Cardiovasc Med. 2025 Mar 18;26(3):25781. doi: 10.31083/RCM25781. eCollection 2025 Mar.
4
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy-Challenges and Prospectives.糖尿病性心肌病药物治疗的批判性评价——挑战与展望
Pharmaceuticals (Basel). 2025 Jan 20;18(1):134. doi: 10.3390/ph18010134.
5
Semaglutide administration protects cardiomyocytes in db/db mice via energetic improvement and mitochondrial quality control.司美格鲁肽给药通过改善能量代谢和线粒体质量控制保护db/db小鼠的心肌细胞。
Acta Pharmacol Sin. 2025 May;46(5):1250-1261. doi: 10.1038/s41401-024-01448-9. Epub 2025 Jan 24.
6
ZIP7 contributes to the pathogenesis of diabetic cardiomyopathy by suppressing mitophagy in mouse hearts.ZIP7 通过抑制小鼠心脏中的线粒体自噬来促进糖尿病心肌病的发病机制。
Cardiovasc Diabetol. 2024 Nov 7;23(1):399. doi: 10.1186/s12933-024-02499-2.
7
MiR-21-3p inhibitor exerts myocardial protective effects by altering macrophage polarization state and reducing excessive mitophagy.miR-21-3p 抑制剂通过改变巨噬细胞极化状态和减少过度自噬发挥心肌保护作用。
Commun Biol. 2024 Oct 22;7(1):1371. doi: 10.1038/s42003-024-07050-3.
8
High glucose- or AGE-induced oxidative stress inhibits hippocampal neuronal mitophagy through the Keap1-Nrf2-PHB2 pathway in diabetic encephalopathy.高糖或 AGE 诱导的氧化应激通过 Keap1-Nrf2-PHB2 通路抑制糖尿病脑病中海马神经元的线粒体自噬。
Sci Rep. 2024 Oct 14;14(1):24044. doi: 10.1038/s41598-024-70584-3.
9
Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs).糖原贮积症(GSDs)中的线粒体功能障碍。
Biomolecules. 2024 Sep 1;14(9):1096. doi: 10.3390/biom14091096.
10
Prevalence and associations of asymptomatic left ventricular systolic dysfunction in Lebanese patients with type 2 diabetes mellitus.黎巴嫩 2 型糖尿病患者无症状左心室收缩功能障碍的患病率及相关因素。
PLoS One. 2024 Sep 18;19(9):e0304801. doi: 10.1371/journal.pone.0304801. eCollection 2024.
JQ1 通过激活 PINK1/Parkin 介导的线粒体自噬来预防高脂肪饮食诱导的糖尿病心肌病。
J Mol Cell Cardiol. 2020 Dec;149:1-14. doi: 10.1016/j.yjmcc.2020.09.003. Epub 2020 Sep 15.
4
FUNDC1 interacts with FBXL2 to govern mitochondrial integrity and cardiac function through an IP3R3-dependent manner in obesity.在肥胖状态下,FUNDC1与FBXL2相互作用,通过依赖三磷酸肌醇受体3(IP3R3)的方式来维持线粒体完整性和心脏功能。
Sci Adv. 2020 Sep 16;6(38). doi: 10.1126/sciadv.abc8561. Print 2020 Sep.
5
Novel Dual-Fluorescent Mitophagy Reporter Reveals a Reduced Mitophagy Flux in Type 1 Diabetic Mouse Heart.新型双荧光自噬报告系统揭示 1 型糖尿病小鼠心脏自噬通量降低。
J Am Osteopath Assoc. 2020 Jul 1;120(7):446-455. doi: 10.7556/jaoa.2020.072.
6
Secreted Frizzled-Related Protein 2 and Extracellular Volume Fraction in Patients with Heart Failure.心力衰竭患者的分泌型卷曲相关蛋白2与细胞外容积分数
Oxid Med Cell Longev. 2020 May 6;2020:2563508. doi: 10.1155/2020/2563508. eCollection 2020.
7
Exogenous HS Promoted USP8 Sulfhydration to Regulate Mitophagy in the Hearts of db/db Mice.外源性硫化氢促进USP8巯基化以调节db/db小鼠心脏中的线粒体自噬。
Aging Dis. 2020 Mar 9;11(2):269-285. doi: 10.14336/AD.2019.0524. eCollection 2020 Apr.
8
AMPK activation induces mitophagy and promotes mitochondrial fission while activating TBK1 in a PINK1-Parkin independent manner.AMPK 的激活诱导了线粒体自噬,并促进了线粒体分裂,同时以 PINK1-Parkin 非依赖性的方式激活了 TBK1。
FASEB J. 2020 May;34(5):6284-6301. doi: 10.1096/fj.201903051R. Epub 2020 Mar 22.
9
Multiple Roles of sFRP2 in Cardiac Development and Cardiovascular Disease.sFRP2 在心脏发育和心血管疾病中的多重作用。
Int J Biol Sci. 2020 Jan 14;16(5):730-738. doi: 10.7150/ijbs.40923. eCollection 2020.
10
Role of Sfrps in cardiovascular disease.分泌型卷曲相关蛋白(Sfrps)在心血管疾病中的作用。
Ther Adv Chronic Dis. 2020 Jan 28;11:2040622320901990. doi: 10.1177/2040622320901990. eCollection 2020.